196 related articles for article (PubMed ID: 18594150)
1. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
2. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
3. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Taniguchi T; Liu FT; Ueno H
Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
[TBL] [Abstract][Full Text] [Related]
4. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
5. Role of VLA-4 in the development of allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
[TBL] [Abstract][Full Text] [Related]
6. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
[TBL] [Abstract][Full Text] [Related]
7. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
Fukushima A; Ozaki A; Jian Z; Ishida W; Fukata K; Ueno H; Liu FT
Curr Eye Res; 2005 Apr; 30(4):241-8. PubMed ID: 15823916
[TBL] [Abstract][Full Text] [Related]
8. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
9. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
Ishida W; Tsuru E; Tominaga A; Miyazaki JI; Higuchi T; Sakamoto S; Fukushima A
Br J Ophthalmol; 2009 Dec; 93(12):1680-5. PubMed ID: 19692377
[TBL] [Abstract][Full Text] [Related]
10. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
Fukushima A; Sumi T; Fukuda K; Yamaguchi T; Kumagai N; Nishida T; Ueno H
Immunol Lett; 2006 Sep; 107(1):32-40. PubMed ID: 16930723
[TBL] [Abstract][Full Text] [Related]
11. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
[TBL] [Abstract][Full Text] [Related]
13. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the interaction between IFN-gamma and IFN-gammaR in the effector phase of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Tsuru E; Ueno H
Immunol Lett; 2006 Nov; 107(2):119-24. PubMed ID: 16987553
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
Fukushima A; Yamaguchi T; Fukuda K; Sumi T; Kumagai N; Nishida T; Imai S; Ueno H
Microbiol Immunol; 2006; 50(9):719-28. PubMed ID: 16985294
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
[TBL] [Abstract][Full Text] [Related]
17. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
18. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
[TBL] [Abstract][Full Text] [Related]
19. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
[TBL] [Abstract][Full Text] [Related]
20. T-cell Ig and mucin domain-containing protein (Tim)-2 regulates murine allergic conjunctivitis during the effector phase.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Immunol Lett; 2007 Jun; 110(2):133-8. PubMed ID: 17532058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
